0

Journal Articles

in Adverse Drug Effects
 61-80 of 83 Articles
Medical News and Perspectives |  June 07, 2006
William R. Barclay, MD, 1919-2006
JAMA. 2006;295(21):2465. doi:10.1001/jama.295.21.2465.
From the Centers for Disease Control and Prevention |  May 17, 2006 FREE
Discontinuation of Spectinomycin
JAMA. 2006;295(19):2241-2245. doi:10.1001/jama.295.19.2245.
Special Communication |  May 04, 2005
The Research on Adverse Drug Events and Reports (RADAR) Project
Charles L. Bennett, MD, PhD, MPP; Jonathan R. Nebeker, MS, MD; E. Allison Lyons, BA; et al.
JAMA. 2005;293(17):2131-2140. doi:10.1001/jama.293.17.2131.
Commentary |  December 01, 2004
Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug Reactions:  A Counterpoint
Brian L. Strom, MD, MPH
JAMA. 2004;292(21):2643-2646. doi:10.1001/jama.292.21.2643.
Controversies |  December 01, 2004
Authors’ Reply to Bayer’s Response to “Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug Reactions: Use of Cerivastatin and Risk of Rhabdomyolysis”
Bruce M. Psaty, MD, PhD; Curt D. Furberg, MD, PhD; Wayne A. Ray, PhD; et al.
JAMA. 2004;292(21):2658-2659. doi:10.1001/jama.292.21.2658.
Controversies |  December 01, 2004
Bayer’s Response to “Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug Reactions: Use of Cerivastatin and Risk of Rhabdomyolysis”
Joseph D. Piorkowski, DO, JD, MPH
JAMA. 2004;292(21):2655-2657. doi:10.1001/jama.292.21.2655.
Editorial |  December 01, 2004
Postmarketing Surveillance—Lack of Vigilance, Lack of Trust
Phil B. Fontanarosa, MD; Drummond Rennie, MD; Catherine D. DeAngelis, MD, MPH
JAMA. 2004;292(21):2647-2650. doi:10.1001/jama.292.21.2647.
Medical News and Perspectives |  November 10, 2004
When Cost Is an Adverse Drug Effect, Patients Cut Corners and Risk Health
JAMA. 2004;292(18):2201-2204. doi:10.1001/jama.292.18.2201.
Health Agencies Update |  February 25, 2004
Red Dress Campaign
JAMA. 2004;291(8):933. doi:10.1001/jama.291.8.933-d.
Original Contribution |  January 21, 2004 FREE
Surveillance of Medical Device–Related Hazards and Adverse Events in Hospitalized Patients
Matthew H. Samore, MD; R. Scott Evans, MS, PhD; April Lassen, RN; et al.
JAMA. 2004;291(3):325-334. doi:10.1001/jama.291.3.325.
Original Contribution |  March 05, 2003 FREE
Incidence and Preventability of Adverse Drug Events Among Older Persons in the Ambulatory Setting
Jerry H. Gurwitz, MD; Terry S. Field, DSc; Leslie R. Harrold, MD, MPH; et al.
JAMA. 2003;289(9):1107-1116. doi:10.1001/jama.289.9.1107.
Special Communication |  February 06, 2002
Nonspecific Medication Side Effects and the Nocebo Phenomenon
Arthur J. Barsky, MD; Ralph Saintfort, MD; Malcolm P. Rogers, MD; et al.
JAMA. 2002;287(5):622-627. doi:10.1001/jama.287.5.622.
Review |  November 14, 2001 FREE
Potential Role of Pharmacogenomics in Reducing Adverse Drug Reactions:  A Systematic Review
Kathryn A. Phillips, PhD; David L. Veenstra, PhD, PharmD; Eyal Oren, BA; et al.
JAMA. 2001;286(18):2270-2279. doi:10.1001/jama.286.18.2270.
The Rational Clinical Examination |  May 16, 2001
Is This Patient Allergic to Penicillin?:  An Evidence-Based Analysis of the Likelihood of Penicillin Allergy
Alan R. Salkind, MD; Paul G. Cuddy, PharmD; John W. Foxworth, PharmD
JAMA. 2001;285(19):2498-2505. doi:10.1001/jama.285.19.2498.
Original Contribution |  April 25, 2001 FREE
Medication Errors and Adverse Drug Events in Pediatric Inpatients
Rainu Kaushal, MD, MPH; David W. Bates, MD, MSc; Christopher Landrigan, MD, MPH; et al.
JAMA. 2001;285(16):2114-2120. doi:10.1001/jama.285.16.2114.
Caring for the Critically Ill Patient |  July 21, 1999 FREE
Pharmacist Participation on Physician Rounds and Adverse Drug Events in the Intensive Care Unit
Lucian L. Leape, MD; David J. Cullen, MD; Margaret Dempsey Clapp, MS, RPh; et al.
JAMA. 1999;282(3):267-270. doi:10.1001/jama.282.3.267.
Editorial |  May 12, 1999
JAMA-EXPRESS: Rapid Peer Review and Publication
Margaret A. Winker, MD; Phil B. Fontanarosa, MD
JAMA. 1999;281(18):1754-1755. doi:10.1001/jama.281.18.1754.
Commentary |  March 03, 1999
Meta-analysis and Epidemiologic Studies in Drug Development and Postmarketing Surveillance
Robert Temple, MD
JAMA. 1999;281(9):841-844. doi:10.1001/jama.281.9.841.
Special Communication |  March 03, 1999
Postmarketing Surveillance and Adverse Drug Reactions:  Current Perspectives and Future Needs
Timothy Brewer, MD, MPH; Graham A. Colditz, MD, DrPH
JAMA. 1999;281(9):824-829. doi:10.1001/jama.281.9.824.
Original Contribution |  October 21, 1998 FREE
A Computer Alert System to Prevent Injury From Adverse Drug Events:  Development and Evaluation in a Community Teaching Hospital
Robert A. Raschke, MD, MS; Bea Gollihare, MS, RN; Thomas A. Wunderlich, RPh; et al.
JAMA. 1998;280(15):1317-1320. doi:10.1001/jama.280.15.1317.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Surgery
Special Feature  |  June 12, 2013
Image of the Month—Diagnosis
JAMA Dermatology
Study  |  February 20, 2013
Saliva Polymerase Chain Reaction Assay for Detection and Follow-up of Herpesvirus Reactivation in Patients With Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS)
Vincent Descamps, MD, PhD; Martine Avenel-Audran, MD; Laurence Valeyrie-Allanore, MD; et al.
JAMA Psychiatry
Original Article  |  March 27, 2013
Effects of Varenicline and Bupropion Sustained-Release Use Plus Intensive Smoking Cessation Counseling on Prolonged Abstinence From Smoking and on Depression, Negative Affect, and Other Symptoms of Nicotine Withdrawal
Paul M. Cinciripini, PhD; Jason D. Robinson, PhD; Maher Karam-Hage, MD; et al.
JAMA Internal Medicine
Original Investigation  |  February 4, 2013
Dietary and Supplemental Calcium Intake and Cardiovascular Disease Mortality:  The National Institutes of Health–AARP Diet and Health Study
Qian Xiao, PhD; Rachel A. Murphy, PhD; Denise K. Houston, PhD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems